ArticleVeterinary world2024
Relationship between urinary neutrophil gelatinase-associated lipocalin and selected biochemical and urinary parameters in dogs naturally infected with
Article in Veterinary world, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Revolutionizing oronasal fistula treatment inOpen veterinary journal · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aim: Materials and Methods: We assessed uNGAL concentrations in 37 privately owned dogs naturally affected by CanL, in which urinary tract infections were excluded based on negative urine culture. No dog exhibited clinical signs related to impaired renal function. uNGAL concentration evaluated in dogs affected by CanL was compared to the one previously analyzed in the control group. Furthermore, the uNGAL concentration was compared between leishmaniasis dogs with biochemical and urinary parameters inside or outside the normal range and between dogs with different clinical stages of leishmaniasis based on the LeishVet clinical staging guidelines and IRIS classification. Results: The median uNGAL concentration in affected dogs was 50.2 ng/mL, which was significantly higher than that in healthy dogs (9.74 ng/mL [p = 0.0025]). uNGAL concentration was significantly higher in proteinuric leishmaniosis dogs than in non-proteinuric leishmaniosis dogs (p = 0.0001). Dogs classified as LeishVet clinical stage III had a higher mean uNGAL concentration than those classified as stage II (p = 0.0001) and median uNGAL concentration was statistically higher in dogs classified as IRIS stage 1 than in dogs affected by CanL with no clinical and pathological signs of renal disease. The amount of proteinuria and urinary sediment hyaline cast per high-power field of the microscope and total serum protein concentrations were significantly correlated with uNGAL concentration. Conclusion: To the best of our knowledge, only a few studies have measured uNGAL in dogs naturally affected by CanL. Although limited by the small number of cases, this study highlighted a significant increase in uNGAL levels in affected dogs compared with healthy dogs and confirmed the correlation between proteinuria and urinary excretion of uNGAL in dogs with leishmaniasis. This suggests that uNGAL can be used as a marker of kidney damage in dogs affected by CanL.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.